Option Care Health offers attractive valuation and consistent earnings execution, but heavy customer and supplier concentration alongside declining earnings estimates and a confirmed downtrend keep the risk profile elevated.
Thesis pillars
- Attractive Valuation Entry↓Deteriorating
- Customer Concentration Risk↑Improving
- Earnings Estimates Declining↑Improving
- +1 more pillar — see the Why tab for full reasoning
Pillars as of Jul 3, 2026, based on the 10-K filed Feb 24, 2026
Option Care Health, Inc. (OPCH) Stock Analysis
Healthcare · Medical Care Facilities
Sell if holding. At $31.29, A.R:R is negative (-1.1) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: MCOs and non-governmental payers (88.0%); Concentration risk — Supplier: four vendors.
Option Care Health operates 196 home and alternate-site infusion pharmacies in 43 states—87 full-service pharmacies plus 109 stand-alone ambulatory infusion suites—delivering anti-infective, immunoglobulin, and biologic therapies under physician direction. Revenue comes from... Read more
Sell if holding. At $31.29, A.R:R is negative (-1.1) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: MCOs and non-governmental payers (88.0%); Concentration risk — Supplier: four vendors. Chart setup: No clear chart pattern; technical signals are mixed. Score 4.8/10, moderate confidence.
Passes 5/10 gates (positive momentum, clean insider activity, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio and death cross (50MA < 200MA) and earnings proximity 5d<=7d. Suitability: aggressive.
Recent developments
updated 2026-10-29Recent Developments — Option Care Health, Inc.
Latest news
- NEWS Option Care Health Inc (OPCH) Valuation: PE, PB & Fair Value Analysis - TradingKey — TradingKey neutral
- NEWS A Look at Option Care Health Inc (OPCH) After 3.2% Decline -- GF Value $42.53 vs Price $26.87 - GuruFocus — GuruFocus negative
- NEWS Option Care Health (OPCH) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance — Yahoo Finance neutral
- NEWS Why Option Care Health Stock Is Sliding Today - TipRanks — TipRanks negative
- NEWS Option Care Health (OPCH) To Report Earnings Tomorrow: Here Is What To Expect - StockStory — StockStory neutral
Generated 2026-10-29T11:53:51Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHCustomerMCOs and non-governmental payers88%10-K Item 1A: '88% of our revenue came from MCOs and other non-governmental payers'
- LOWCustomerlargest payer14%10-K Item 1: 'The Company's largest payer represented approximately 14% of its revenue for the year ended December 31, 2025.'
- LOWregulatoryMedicare and Medicaid12%10-K Item 1: 'approximately 12% of the Company's revenue was reimbursable through direct government healthcare programs, such as Medicare and Medicaid.'
- HIGHSupplierfour vendors10-K Item 1A: 'approximately 68% of our pharmaceutical and medical supply purchases were from four vendors'
Material Events(8-K, last 90d)
- 2026-05-05Item 5.02LOWChief Growth Officer Christopher L. Grashoff to depart effective May 8, 2026. Entitled to separation benefits under the Amended and Restated Executive Severance Plan conditioned on release of claims. No successor named.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
3 floor-breakers
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. At $31.29, A.R:R is negative (-1.1) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: MCOs and non-governmental payers (88.0%); Concentration risk — Supplier: four vendors. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $31.09. Score 4.8/10, moderate confidence.
Analyst target $26.13 reached (−16.5% from $31.29); no take-profit level is published. Prior stop was $31.09. Stop-loss: $31.09.
Concentration risk — Customer: MCOs and non-governmental payers (88.0%); Concentration risk — Supplier: four vendors; Analyst target reached - limited upside remaining.
Option Care Health, Inc. trades at a P/E of 23.7 (forward 15.0). TrendMatrix value score: 5.7/10. Verdict: Sell.
19 analysts cover OPCH with a consensus score of 3.9/5. Average price target: $30.
What does Option Care Health, Inc. do?Option Care Health operates 196 home and alternate-site infusion pharmacies in 43 states—87 full-service pharmacies...
Option Care Health operates 196 home and alternate-site infusion pharmacies in 43 states—87 full-service pharmacies plus 109 stand-alone ambulatory infusion suites—delivering anti-infective, immunoglobulin, and biologic therapies under physician direction. Revenue comes from reimbursements by MCOs, Medicare, Medicaid, and commercial payers for pharmaceuticals dispensed and nursing services, with 6,528 full-time and 1,738 part-time employees at year-end 2025.